Are you Dr. Barker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
317 N Mission St
Ste 200
Wenatchee, WA 98801Phone+1 509-663-8711
Summary
- Dr. Andrew Barker, DO is a physiatrist in Wenatchee, Washington. He is currently licensed to practice medicine in Washington, Arizona, and Illinois.
Education & Training
Loyola University Medical CenterResidency, Physical Medicine and Rehabilitation, 2003 - 2006
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2002
Certifications & Licensure
WA State License 2019 - 2025
AZ State License 2010 - 2019
MI State License 2002 - 2012
IL State License 2003 - 2006- American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
Publications & Presentations
PubMed
- 383 citationsStudies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatm...Barker Andrew John, Keith Hopkinson Gibson, Walter Grundy, Godfrey Andrew Aydon, Jeffrey J Barlow
Bioorganic & Medicinal Chemistry Letters. 2001-07-23 - 33 citationsThe Discovery of Azd5597, a Potent Imidazole Pyrimidine Amide Cdk Inhibitor Suitable for Intravenous Dosing.Clifford David Jones, David M. Andrews, Barker Andrew John, Kevin Blades, Paula Daunt
Bioorganic & Medicinal Chemistry Letters. 2008-12-15 - 22 citationsImidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitors.Clifford David Jones, David M. Andrews, Barker Andrew John, Kevin Blades, Kate Byth
Bioorganic & Medicinal Chemistry Letters. 2008-12-15
